A phase II study to evaluate the efficacy and safety of oral fludarabine phosphate in combination with mitoxantrone as first-line treatment in follicular NHL.
Phase of Trial: Phase II
Latest Information Update: 24 Aug 2013
At a glance
- Drugs Fludarabine; Mitoxantrone
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 28 Jul 2010 Genzyme added as trial sponsor and affiliate as reported by ClinicalTrials.gov.
- 14 Jul 2009 Actual patient numbers changed from 60 to 62 as reported by ClinicalTrials.gov.
- 27 Oct 2008 Actual start date changed from Jul 2004 to Jun 2004 as reported by ClinicalTrials.gov.